Suchergebnisse - "Saito, Kosuke"

PubPharm (195)

101

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus

enthalten in: Frontiers in pharmacology | 2017

von Esaki, H. | Tachi, T. | Goto, C. | +11

102

Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis

enthalten in: Journal of applied toxicology | 2017

von Saito, K. | Goda, K. | Kobayashi, A. | +4

103

Arachidonic acid‐containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen‐induced hepatic phospholipidosis

enthalten in: Journal of applied toxicology | 2017

von Saito, K. | Goda, K. | Kobayashi, A. | +4

104

Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma

enthalten in: Scientific reports | 2016

von Saito, K. | Arai, E. | Maekawa, K. | +6

105

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Nishimura, M. | Toyoda, M. | Takenaka, K. | +9

106

Phenobarbital and Insulin Reciprocate Activation of the Nuclear Receptor Constitutive Androstane Receptor through the Insulin Receptor

enthalten in: The Journal of pharmacology and experimental therapeutics | 2016

von Yasujima, T. | Saito, K. | Moore, R. | +1

107

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Nishimura, M. | Toyoda, M. | Takenaka, K. | +9

108

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Nishimura, M. | Toyoda, M. | Takenaka, K. | +9

109

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Nishimura, M. | Toyoda, M. | Takenaka, K. | +9

110

Tumor-selective mitochondrial network collapse induced by atmospheric gas plasma-activated medium

enthalten in: Oncotarget | 2016

von Saito, K. | Asai, T. | Fujiwara, K. | +6